Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Mottok

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Haematologica|October 15, 2020
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RASMarcel Seibold, Thorsten Stühmer, Nadine Kremer, et al.
American Journal of Hematology|August 10, 2019
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphomaSylvia Hartmann, Annette Plütschow, Anja Mottok, et al.
Blood|May 28, 2015
Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHDMartin Chopra, Andreas Brandl, Daniela Siegmund, et al.
British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.
Blood|October 9, 2013
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
Blood|February 3, 2016
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCLKerry J Savage, Graham W Slack, Anja Mottok, et al.
Cell Reports|November 10, 2015
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II ExpressionAnja Mottok, Bruce Woolcock, Fong Chun Chan, et al.
Carcinogenesis|February 7, 2013
Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasisMartin Chopra, Simone S Riedel, Marlene Biehl, et al.
Frontiers in Immunology|February 15, 2021
A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host DiseaseCarina A Bäuerlein, Musga Qureischi, Zeinab Mokhtari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2017
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin LymphomaFong Chun Chan, Anja Mottok, Alina S Gerrie, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Haematologica|October 15, 2020
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RASMarcel Seibold, Thorsten Stühmer, Nadine Kremer, et al.
American Journal of Hematology|August 10, 2019
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphomaSylvia Hartmann, Annette Plütschow, Anja Mottok, et al.
Blood|May 28, 2015
Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHDMartin Chopra, Andreas Brandl, Daniela Siegmund, et al.
British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.
Blood|October 9, 2013
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
Blood|February 3, 2016
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCLKerry J Savage, Graham W Slack, Anja Mottok, et al.
Cell Reports|November 10, 2015
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II ExpressionAnja Mottok, Bruce Woolcock, Fong Chun Chan, et al.
Carcinogenesis|February 7, 2013
Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasisMartin Chopra, Simone S Riedel, Marlene Biehl, et al.
Frontiers in Immunology|February 15, 2021
A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host DiseaseCarina A Bäuerlein, Musga Qureischi, Zeinab Mokhtari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2017
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin LymphomaFong Chun Chan, Anja Mottok, Alina S Gerrie, et al.
Pageof 9